Cipher Surgical Raises $10M in Series A Funding to Advance Continuous Intra-Abdominal Vision Technology

Cipher Surgical is thrilled to announce a successful funding announcement of $10,000,000 aimed at accelerating its innovative mission in the field of medical devices. Established in 2010, Cipher Surgical has been a pioneer of surgical innovation, having already transformed laparoscopic procedures with its groundbreaking OpClear platform. This cutting-edge technology provides continuous intra-abdominal vision to the surgical team, ensuring steady surgical flow and reducing the likelihood of errors. The infusion of capital will primarily support efforts to further refine the OpClear platform—a device designed to address longstanding challenges in surgery by automating CO2 flow and providing on-demand saline lens washes for unobstructed views during complex procedures. This significant deployment of funds will drive research and development initiatives, enabling Cipher Surgical to enhance the platform’s capabilities, extend its usability, and ultimately improve patient outcomes. By clearing obstructive elements such as blood and energy plume particles instantaneously, the OpClear system minimizes the need for scope removal, resulting in shorter operating times and a decrease in surgical complications. In an era where precision and efficiency in the operating room are paramount, this funding reinforces Cipher Surgical’s commitment to shaping the future of laparoscopic surgery. Moreover, with this financial boost, the company plans to expand its market presence and cultivate partnerships with leading healthcare institutions worldwide, further solidifying its position as an industry trailblazer. The investment not only underscores confidence in Cipher Surgical's innovative approach but also promises to deliver transformative impact across surgical practices and patient care globally.